CIK 0001652130
- Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364785571
- Phone
- +1 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $167,285
- in 3 filings, $144K under 10b5-1 plans
Net −$167,285. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-01 | LEONARD JOHN M. President and CEO | Exercise or conversion | +5,000 | $6.83 | $34K | 472,352 |
| 2020-09-01 | LEONARD JOHN M. President and CEO | Sale | −5,000 | $21.83 | $109K | 467,352 |
| 2020-09-01 | LEONARD JOHN M. President and CEO | Exercise or conversion · Stock Option (right to buy) | −5,000 | 330,234 | ||
| 2020-08-06 | LEONARD JOHN M. President and CEO | Exercise or conversion | +5,000 | $6.83 | $34K | 472,352 |
| 2020-08-06 | LEONARD JOHN M. President and CEO | Sale | −5,000 | $21.83 | $109K | 467,352 |
| 2020-08-06 | LEONARD JOHN M. President and CEO | Exercise or conversion · Stock Option (right to buy) | −5,000 | 335,234 | ||
| 2020-07-01 | LEONARD JOHN M. President and CEO | Exercise or conversion | +5,000 | $6.83 | $34K | 472,352 |
| 2020-07-01 | LEONARD JOHN M. President and CEO | Sale | −5,000 | $21.83 | $109K | 467,352 |
| 2020-07-01 | LEONARD JOHN M. President and CEO | Exercise or conversion · Stock Option (right to buy) | −5,000 | 340,234 | ||
| 2020-06-03 | LEONARD JOHN M. President and CEO | Exercise or conversion | +5,000 | $6.83 | $34K | 472,352 |
| 2020-06-03 | LEONARD JOHN M. President and CEO | Sale | −5,000 | $21.83 | $109K | 467,352 |
| 2020-06-03 | LEONARD JOHN M. President and CEO | Exercise or conversion · Stock Option (right to buy) | −5,000 | 345,234 | ||
| 2020-03-02 | LEONARD JOHN M. President and CEO | Grant or award · Stock Option (Right to Buy) | +340,000 | 340,000 | ||
| 2018-12-18 | LEONARD JOHN M. President and CEO | Grant or award · Stock Option (right to buy) | +240,000 | 240,000 | ||
| 2018-05-14 | LEONARD JOHN M. President and CEO | Sale | −8,400 | $24.00 | $202K | 0 |
| 2018-01-25 | LEONARD JOHN M. CEO | Grant or award · Stock Option (right to buy) | +220,000 | 220,000 | ||
| 2017-12-12 | LEONARD JOHN M. EVP, R&D | Grant or award · Stock Option (right to buy) | +72,500 | 72,500 | ||
| 2017-06-01 | LEONARD JOHN M. EVP, R&D | Grant or award | +7,800 | $12.06 | $94K | 7,800 |
| 2017-06-01 | LEONARD JOHN M. EVP, R&D | Grant or award | +600 | $12.09 | $7K | 8,400 |
| 2017-01-06 | LEONARD JOHN M. EVP, R&D | Grant or award · Stock Option (right to buy) | +95,000 | 95,000 |
Page 1 of 1 · 20 trades